Skip to content
Download PDF

Trigeminal Neuralgia, Bell's Palsy, and Other Cranial Nerve Disorders

Chapter 452 | Part 13: Neurologic Disorders · Part 13 – Neurologic Disorders · Chapter 452

Key Clinical Points

  1. Trigeminal neuralgia (TN) is characterized by excruciating paroxysms of pain in the lips, gums, cheek, or chin, triggered by tactile stimuli (trigger zones).
  2. Objective signs of sensory loss cannot be demonstrated on examination in classic trigeminal neuralgia.
  3. Bell's palsy is the most common form of facial paralysis; 80% of patients recover within a few weeks or months.
  4. Supranuclear facial palsy spares the forehead (frontalis and orbicularis oculi) because upper facial muscles are innervated by corticobulbar pathways from both motor cortices.
  5. Carbamazepine is effective in ~50–75% of trigeminal neuralgia patients; doses >1200 mg daily provide no additional benefit.
  6. Prednisone 60–80 mg daily for the first 5 days modestly shortens recovery in Bell's palsy.
  7. Ramsay Hunt syndrome consists of severe facial palsy associated with a vesicular eruption in the external auditory canal.
  8. Cavernous sinus syndrome is a distinctive and frequently life-threatening disorder often presenting with orbital pain and oculomotor neuropathy (III, IV, V1, V2, VI).
  9. Glossopharyngeal neuralgia pain originates on one side of the throat, approximately in the tonsillar fossa, and may be initiated by swallowing or coughing.
  10. Isolated sensory loss over the chin (mental neuropathy) can be the only manifestation of systemic malignancy.

DEFINITION & OVERVIEW

• Cranial Nerves: 12 paired nerves mediating motor, sensory, and autonomic functions. They are grouped due to close anatomical relationships to the brainstem. • Anatomical Exceptions: CN I (olfactory) and CN II (optic) are fiber tracts of the brain; CN XI (spinal accessory) has motor neurons in the upper cervical cord. • Trigeminal Nerve (CN V): ◦ Supplies sensation to the skin of the face, anterior half of the head, and nasal/oral mucosa. ◦ Motor component innervates muscles for chewing (masseter, temporalis, pterygoids), anterior belly of digastric, mylohyoid, tensor veli palatini, and tensor tympani. ◦ Unique Feature: Predominantly ensheathed by oligodendrocyte-derived myelin for up to 7 mm after leaving the brainstem; this may explain some cases of TN in multiple sclerosis (MS). • Facial Nerve (CN VII): ◦ Supplies all muscles of facial expression, stapedius, stylohyard, and posterior belly of digastric. ◦ Contains sensory/parasympathetic components (nervus intermedius) for taste (anterior 2/3 of tongue), cutaneous impulses from the external auditory canal, and preganglionic parasympathetic signals to the pterygopalatine and submandibular glands. • Glossopharyngeal Nerve (CN IX): ◦ Conveys somatic sensation from pharynx, middle ear, tympanic membrane, eustachian tube, and posterior third of tongue; taste from posterior third of tongue; and baroreceptor info to the nucleus solitarius. ◦ Motor function is limited to the stylopharyngeus muscle. • Vagus Nerve (CN X): ◦ Carries somatic sensation from posterior external auditory canal and posterior pinna. ◦ Clinical Note: Recurrent laryngeal nerves, especially the left, are most often damaged in introthoracic disease.

EPIDEMIOLOGY

• Trigeminal Neuralgia (TN): → Incidence: 4–8 per 100,000 annually. → Demographics: Primarily middle-aged and elderly; ~60% of cases in women. → Course: Sudden onset; paroxysms last seconds to minutes; often recurs after long periods of remission. • Bell's Palsy: → Incidence: ~25 per 100,000 annually (approx. 1 in 60 people in a lifetime). → Risk Factors: Pregnancy and diabetes mellitus. → Recurrence: Reported in ~7% of cases.

ETIOLOGY & PATHOPHYSIOLOGY

• Trigeminal Neuralgia (TN): → Mechanism: Ectopic generation of pain from action potentials in pain-sensitive afferent fibers just before the nerve enters the lateral surface of the pons. → Pathophysiology: Compression/pathology leads to demyelination of large myelinated fibers → these become hyperexcitable and electrically coupled with smaller unmyelinated pain fibers → tactile stimuli (via large fibers) trigger paroxysms of pain. → Common Cause: Compression by a blood vessel (most often the superior cerebellar artery or a tortuous vein). → MS Association: If TN occurs in young adults or is bilateral, MS is a key consideration (demyelinating plaque near the root entry zone). • Bell's Palsy: → Pathophysiology: Inflammation of the facial nerve with mononuclear cells. → Viral Etiology: HSV-1 (frequently detected) and VZV (up to 1/3 of cases). Other viruses like SARS-CoV-2 or HIV seroconversion may be involved. • Trigeminal Neuropathy: → Causes: Sjögren's syndrome, collagen-vascular diseases (SLE, scleroderma, MCTD), and mass lesions (aneurysms, neurofibromas, schwannomas, meningiomas).

CLINICAL FEATURES

• Trigeminal Neuralgia: → Pain: Excruciating paroxysms; sudden, lancinating (shock-like) pain. → Duration: Seconds to 1–2 minutes. → Triggers: Speaking, chewing, smiling, or tactile stimuli (washing face, brushing teeth, draft of air). → Key Finding: No objective signs of sensory loss on examination. • Bell's Palsy: → Onset: Abrupt; maximal weakness reached by 48 hours. → Associated Symptoms: Pain behind the ear (1–2 days prior), unilateral taste loss, hyperacusis. → Prognosis: Presence of incomplete paralysis in the first week is the most favorable prognostic sign. → EMG: Denervation after 10 days indicates axonal degeneration → long delay (3 months) before regeneration. • Hemifacial Spasm: → Presentation: Painless irregular involuntary contractions on one side of the face. → Cause: Often related to vascular compression of the exiting facial nerve in the pons. • Glossopharyngeal Neuralgia: → Location: One side of the throat, approximately in the tonsillar fossa. → Triggers: Swallowing or coughing. • Vagus Nerve Disorders: → Symptoms: Loss of sensation at external meatus/posterior pinna; hoarseness (if recurrent laryngeal nerve involved).

DIFFERENTIAL DIAGNOSIS

• Trigeminal Neuralgia vs. Other Headaches: → Distinction: TN is differentiated from other conditions like 'short-lasting, unilateral headache attacks' (cluster headaches) based on clinical presentation and anatomical origin. • Facial Palsy Types: → Supranuclear: Spares the forehead (frontalis/orbicularis oculi) due to bilateral corticobulbar innervation → indicates central pathology. → Nuclear/Peripheral: Involves the entire half of the face; may be caused by tumors, infection, or MS. • Trigeminal Neuropathy: → Distinguished from TN by the presence of objective signs of sensory loss (e.g., in cases involving Sjögren's, SLE, or mass lesions).

DIAGNOSTIC APPROACH

  1. Clinical Localization:
  2. Identify if symptoms are localized to a single nerve or multiple nerves.
  3. Determine if the lesion is in the brainstem (multiple adjacent nerves) or outside (e.g., skull base, cavernous sinus).
  4. Imaging for Trigeminal Neuralgia:
  5. Rule out mass lesions (aneurysms, schwannomas, meningiomas) → especially if patient is young or symptoms are bilateral.
  6. Imaging for Facial Nerve:
  7. MRI with gadolinium/fat suppression to evaluate the geniculate ganglion and facial nerve path (look for 'diffuse smooth linear enhancement').
  8. Evaluation of Cavernous Sinus:
  9. If multiple cranial nerves (III, IV, V1, V2, VI) are involved → suspect cavernous sinus syndrome.
  10. Neurological Assessment:
  11. Assess for supranuclear vs. nuclear palsy to differentiate central from peripheral pathology.

MANAGEMENT & TREATMENT

  1. Trigeminal Neuralgia Treatment:
  2. First-line: Carbamazepine.
  3. Dosage: Effective in 50–75% of patients; doses >1200 mg daily provide no additional benefit.
  4. Bell's Palsy Treatment:
  5. Corticosteroids: Prednisone 60–80 mg daily for the first 5 days → modestly shortens recovery time.
  6. Monitoring & Follow-up:
  7. EMG may be used to assess axonal degeneration if progression is unclear.

PROGNOSIS & COMPLICATIONS

• Trigeminal Neuralgia: → Generally good, but symptoms often recur after long periods of remission. • Bell's Palsy: → 80% recover within weeks/months; recurrence in ~7% of cases. • Cavernous Sinus Syndrome: → Potential for life-threatening complications (e.g., infection, thrombosis) → requires early diagnosis.

SPECIAL CONSIDERATIONS

• Systemic Diseases: → Sjögren's syndrome and collagen-vascular diseases (SLE, scleroderma, MCTD) can cause trigeminal neuropathy. → Sarcoidosis and Leprosy can involve the facial nerve. • Malignancy: → Isolated mental neuropathy (sensory loss over chin) may be the only sign of systemic malignancy. • Vagus Nerve Injury: → Left recurrent laryngeal nerve is more commonly damaged in intrathoracic disease.

KEY PEARLS & CLINICAL TRAPS

• Trigeminal Neuralgia Rule: No objective sensory loss on exam → suggests a primary nerve pathology rather than a mass lesion. • Supranuclear vs. Nuclear: Supranuclear palsy spares the forehead; nuclear/peripheral palsy involves the whole half of the face. • Cavernous Sinus Syndrome: Involvement of III, IV, V1, and VI → highly suggestive of cavernous sinus pathology (e.g., aneurysm or infection). • Trigeminal Nerve Anatomy: The trigeminal nerve is uniquely enveloped by oligodendrocyte-derived myelin for up to 7 mm after leaving the brainstem, making it susceptible to MS. • Vagus Nerve Injury: Left recurrent laryngeal nerve is more commonly damaged in intrathoracic disease.

Reference Tables

TABLE 452-1 Trigeminal Nerve Disorders Nuclear (Brainstem) Lesions Multiple sclerosis Stroke Syringobulbia Glioma…

Harrison's 22e, p.3553

  • Nuclear (Brainstem) Lesions
  • Multiple sclerosis
    Stroke
    Syringobulbia
    Glioma
    Lymphoma
  • Preganglionic Lesions
  • Acoustic neuroma
    Meningioma
    Metastasis
    Chronic meningitis
    Cavernous carotid aneurysm
  • Semilunar Ganglion Lesions
  • Trigeminal neuroma
    Herpes zoster
    Infection (spread from otitis media or mastoiditis)
  • Cavernous Sinus Lesions (see Table 452-2)
  • Peripheral Nerve Lesions
  • Tumor (e.g., nasopharyngeal carcinoma, squamous cell carcinoma, lymphoma)
    Trauma
    Guillain-Barré syndrome
    Sjögren’s syndrome
    Collagen-vascular diseases
    Sarcoidosis
    Leprosy
    Drugs (stilbamidine, trichloroethylene)
    Idiopathic trigeminal neuropathy

TABLE 452-2 Cranial Nerve Syndromes SITE Orbital apex

Harrison's 22e, p.3558

SITE CRANIAL NERVES USUAL CAUSE
Orbital apex II, III, IV, first division
V, VI		 Invasive fungal infections,
amyloidosis, granulomatous
disease
III, IV, first division V, VI
Lateral wall of
cavernous sinus		 III, IV, first division V,
VI, often with proptosis		 Infection, thrombosis, aneurysm
or fistula of cavernous sinus;
invasive tumors from sinuses and
sella turcica; benign granuloma
responsive to glucocorticoids
II, III, IV, V, VI
Apex of petrous
bone		 V, VI Petrositis; tumors of petrous bone
VII, VIII
Pontocerebellar
angle		 V, VI, VII, VIII, and
sometimes IX		 Acoustic neuroma; meningioma
IX, X, XI
Posterior
laterocondylar
space		 IX, X, XI, XII Tumors of parotid gland and
carotid body and metastatic
tumors
IX, X, XI, XII, and
Horner’s syndrome